AT&T's $250 Billion Capex Plan Sparks Options Selloff as Execution Risk Rises

The market's attention is laser-focused on two very different stories this week, driving a surge in search volume and heavy bets in the options market. The main characters are clear: AT&T, with its massive capital plan, and Johnson &Johnson, heading into its earnings report.

First, the search data tells the story. In the last week, interest in 'AT&T capex' has spiked, reflecting intense scrutiny of the company's $250 billion long-term plan. At the same time, searches for 'JNJ earnings' are climbing as the healthcare giant approaches its report. This isn't just background noise; it's the market's way of signaling where the hottest financial headlines are.

The institutional moves for AT&T show a classic split. On one side, Mackenzie Financial Corp cut its stake by 44.6%, a clear vote of caution. On the other, Norges Bank bought a new $2.2 billion stake, betting big on the long-term vision. This tug-of-war in the capital flows mirrors the debate in the options market, where the heavy betting is on the downside. Traders have placed a large put spread, a bet that the stock will fall, likely in response to the near-term cash-flow and execution risks some analysts warn about.

For Johnson & Johnson, the options activity and analyst sentiment paint a picture of cautious support. The stock has a consensus recommendation of "Moderate Buy", but the recent downgrade from a 'strong-buy' to a 'hold' rating by Freedom Capital adds a note of caution. This setup suggests the market is watching JNJ's earnings for confirmation of its steady, if unspectacular, performance, and options traders positioning for a potential move around the report date.

The bottom line is that AT&T is the headline story, capturing search buzz and heavy options betting on its transformative plan. JNJ is the earnings story, with a supportive but slightly tempered analyst view. In a week of shifting focus, these are the two stocks where the market's attention-and its capital-is concentrated.

The Catalysts & Metrics: Connecting Headlines to Financials

The search buzz and options activity point to the headlines, but the real test is how well the underlying business cases support them. Let's break down the financial drivers and risks for each stock.

For AT&T, the headline is its $250 billion capital plan. That's a massive catalyst, promising long-term transformation. Yet the financial reality is a different story. The stock carries a "Risky" rating for good reason. Its operating performance is weak, with top-line growth averaging just 1.1% over the last three years. This disconnect is critical. A low valuation might look appealing, but the market is pricing in the execution risk of funding this plan while growth stagnates. The catalyst is huge, but the business case is fragile.

Macy's presents a more straightforward earnings story. The catalyst is the report itself, and the key metric is momentum. The stock has been trading near the top of its 52-week range and just posted a 0.52% rise in its latest session. The financials show a mixed picture: revenue is down year-over-year, but net income has exploded thanks to cost cuts. The setup is about whether this price momentum holds or if the underlying sales weakness will resurface. The market is watching for confirmation that the recent rally isn't just a technical bounce.

Johnson & Johnson's story is about stability and pipeline news. The average analyst target of $235.91 reflects a steady, if unspectacular, outlook. The recent downgrade from a "strong-buy" to a "hold" rating adds a note of caution, while insider selling pressure introduces a subtle red flag. The dividend is a core pillar, but the real catalysts are in the pipeline-like the recent FDA approval for a new eye lens. The market is looking for that next commercial win to reignite growth.

Finally, Micron is the pure-play AI chip story. The stock's recent valuation score of 2 out of 6 and a DCF suggesting 112.4% overvaluation signal extreme optimism is already priced in. The catalyst is demand for AI workloads, but the valuation metrics suggest the market has already baked in a best-case scenario. Any stumble in that demand could quickly deflate the premium. For now, the story is about whether the financials can justify the lofty price.

The Bottom Line: Which Stock is the Main Character?

The search data and options flow have identified the main characters for this week's financial drama. Each stock is the central player in a specific, high-interest story. Here's how to trade them.

For AT&T, the main character is the telecom capex story. The stock is the clear focus of intense market attention, with 'AT&T capex' searches spiking. This is a pure news trade. The catalyst is massive, but the financials are weak, leading to a "Risky" rating. The options market is betting on a downside move, and institutional selling from Mackenzie Financial adds a guardrail. This setup is for traders chasing the headline, not for long-term investors.

Macy's is the main character for the retail earnings story. The stock is a straightforward bet on the Q4 report, with the catalyst being the upcoming earnings date. The setup is clear: the stock is trading near the top of its 52-week range, showing momentum. The financials are mixed, but the market is focused on whether the recent rally holds. This is a classic pre-earnings play, where the stock's position near its highs makes it sensitive to any miss.

Micron is the main character for the AI semiconductor demand story. The stock is the pure-play beneficiary of the AI hype cycle. However, the extreme valuation metrics tell the real story. With a valuation score of 2 out of 6, the bullish case is fully priced in. The recent price run shows how sensitive it is to any shift in demand sentiment. This is a trade on the headline, but the guardrail is the sky-high valuation.

Johnson & Johnson is the main character for steady dividend income. It's the defensive play, the stock that pays you while you wait. The average analyst target of $235.91 reflects a stable outlook. Yet, recent analyst downgrades and insider selling introduce headline risk. This is a hold-and-collect story, where the main character is the reliable dividend, not explosive growth.